Disposition of tradable shares by Oneil Tara of MultiPlan subject to Rule 16b-3
| MPLN Stock | USD 7.30 0.36 5.19% |
About 72 percent of all MultiPlan's investors are curious in acquiring. The analysis of overall sentiment of trading MultiPlan stock suggests that quite a few investors are confidant at this time. MultiPlan's investing sentiment overview a quick insight into current market opportunities from investing in MultiPlan. Many technical investors use MultiPlan stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
MultiPlan |
Filed transaction by MultiPlan Officer: Svp, General Counsel. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Cash Flow Correlation
MultiPlan's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the MultiPlan's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
MultiPlan Fundamental Analysis
We analyze MultiPlan's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MultiPlan using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MultiPlan based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
MultiPlan is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
MultiPlan Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MultiPlan stock to make a market-neutral strategy. Peer analysis of MultiPlan could also be used in its relative valuation, which is a method of valuing MultiPlan by comparing valuation metrics with similar companies.
Peers
MultiPlan Related Equities
| BFRG | Bullfrog | 12.69 | ||||
| NUTX | Nutex Health | 3.98 | ||||
| DH | Definitive Healthcare | 1.83 | ||||
| BEAT | Heartbeam | 1.43 | ||||
| HSTM | HealthStream | 1.06 | ||||
| CMAX | CareMax | 4.17 | ||||
| EUDA | EUDA Health | 4.64 | ||||
| LIFW | MSP Recovery | 10.42 | ||||
| HCTI | Healthcare Triangle | 18.35 | ||||
| FOXO | FOXO Technologies | 27.78 |
Check out MultiPlan Hype Analysis, MultiPlan Correlation and MultiPlan Performance. To learn how to invest in MultiPlan Stock, please use our How to Invest in MultiPlan guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MultiPlan. If investors know MultiPlan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MultiPlan listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share (95.28) | Revenue Per Share 58.328 | Quarterly Revenue Growth (0.05) | Return On Assets 0.0129 |
The market value of MultiPlan is measured differently than its book value, which is the value of MultiPlan that is recorded on the company's balance sheet. Investors also form their own opinion of MultiPlan's value that differs from its market value or its book value, called intrinsic value, which is MultiPlan's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MultiPlan's market value can be influenced by many factors that don't directly affect MultiPlan's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MultiPlan's value and its price as these two are different measures arrived at by different means. Investors typically determine if MultiPlan is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MultiPlan's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.